COVID-19 and ECMO: the Interplay Between Coagulation and Inflammation—a Narrative Review
The present review summarizes the evidence on ECMO management of severe ARDS in light of recent COVID-19 pandemic, at the same time focusing on differences and similarities between SARS-CoV-2 and ECMO in terms of hematological and inflammatory interplay when these two settings merge.
Should COVID-19 Take Advice from Rheumatologists?
Although the degree and extent of systemic inflammation seen in patients with COVID-19 is typically less than in haemophagocytic lymphohistocytosis and macrophage activation syndrome, many observational studies have identified associations between inflammatory biomarkers
COVID-19 in Cardiac Surgery: A Proposed Prioritization Framework
A prioritization framework based on already published risks scores and guidelines for appropriate use are described as an added tool to supplement thorough patient assessment and sound clinical judgment.
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
We assessed association between administration of in-hospital AC and survival in a large cohort of hospitalized patients with COVID-19.
High Risk of Thrombosis in Patients with Severe SARS-CoV-2 Infection: a Multicenter Prospective Cohort Study
Despite anticoagulation, a high number of patients with ARDS secondary to COVID-19 developed life-threatening thrombotic complications. Higher anticoagulation targets than in usual critically ill patients should therefore probably be suggested.
Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership
As regions move along the journey of managing the COVID-19 pandemic, there is an opportunity to reintroduce regular cardiovascular care in a progressive manner with appropriate safeguards.
Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery
These are guidance recommendations during a pandemic surge to be utilized for ALL patients while local COVID-19 disease burden remains elevated.
Clinical and Laboratory Predictors of In-Hospital Mortality in Patients with COVID-19: a Cohort Study in Wuhan, China
We developed two predictive models for the in-hospital mortality of patients with COVID-19 in Wuhan and validated in patients from another center.
Anesthesia and COVID-19: What We Should Know and What We Should Do
Through a comprehensive review of existing studies on COVID-19, this article presents the epidemiological and clinical characteristics of COVID-19, reviews current medical management, and suggests ways to improve the safety of anesthetic procedures.
Characteristics, Treatment, Outcomes and Cause of Death of Invasively Ventilated Patients with COVID-19 ARDS in Milan, Italy
Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors.
NIH COVID-19 Treatment Guidelines
These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19.
Incidence of Thrombotic Complications in Critically Ill ICU Patients with COVID-19
Our findings reinforce the recommendation to strictly apply pharmacological thrombosis prophylaxis in all COVID-19 patients admitted to the ICU, and are strongly suggestive of increasing the prophylaxis towards high-prophylactic doses, even in the absence of randomized evidence.